Brighter AB announced that Actiste®, for the first time, is prescribed to a patient living with diabetes in Qatar. Dr. Omar Mashhor at the Future Medical Center in Qatar who is the first physician in Qatar to prescribe the device is optimistic about company's offer, in terms of real-life data and other features. The first patient being prescribed the Actiste® device means that the first phase of company's commercialization in Qatar has been successful.

The company is also working closely with its distributor who, once validation of the product is done, will be able to take part in public procurement bids.